With plans of creeping in share acquisition, promoters of Elder Pharmaceuticals have entered in talks with some Japanese companies to supply bulk drugs. The company would start marketing the products in Japan in the next three to four months.
The pharma major recently received an accreditation from the Ministry of Health, Japan for their API plant in Maharashtra. Talking to CNBC-TV18, director Alok Saxena said that the accreditation would help enter grow in the Japanese pharma market.
Elder Pharma stock price
On December 01, 2015, at 13:07 hrs Elder Pharmaceuticals was quoting at Rs 87.00, up Rs 0.75, or 0.87 percent. The 52-week high of the share was Rs 167.00 and the 52-week low was Rs 66.65.
The latest book value of the company is Rs 382.51 per share. At current value, the price-to-book value of the company was 0.23.
Set email alert for
ADS BY GOOGLE
video of the day
Mkt resilient at current level; bullish auto: ICICI Pru AMC